Design and Syntheses of Biologically Functional Molecules Based on the Mechanisms of Life
基于生命机制的生物功能分子的设计与合成
基本信息
- 批准号:11470469
- 负责人:
- 金额:$ 7.55万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We studied the four subjects and obtained the results shown below:(1) We have succeeded to synthesize 2'-0,4'-C-methylene bridged nucleic acid analogs (BNAs) and oligonucleotides containing the BNA (BNA-ODNs). The BNA-ODNs were found to have more effective duplex and triplex forming ability than natural ODNs and modified ODNs ever reported. Comparison of various properties of BNA-ODNs with those of natural ODNs and S-ODNs showed that the BNA-ODNs have an excellent antisense ability.(2). We have designed and synthesized novel chiral vitamin B_6 model compounds having a chiral ansa-structure and/or a chiral ionophore structure, which were found to be effective for asymmetric α-alkylation ofα-amino esters and petides at the N-terminal position. Catalytic β-replacement reaction of a Ser derivative with thiols was also successfully achieved by employing the pyridoxal model compounds.(3) We have synthesized fire-fly luciferin analogs having a heterocyclic structure in place of the benzothiazole structure of the fire-fly luciferin molecule, and studied their bioluminescent and chemiluminescent activities. As a result, it was found that the benzimidazole derivative shows effective light-emmisio by treatment with luciferase, while the benzoxazole derivative is effective for chemiluminescent induced by oxidative treatment.(4) We have synthesized cationic lipid having a symmetrical structure, and studied gene transfection activity of liposome prepared from the lipid. As a consequence, it was found that the liposome composed of the symmetrical lipid, which was more easily prepared than that having an unsymmetrical structure, is low toxic and effective for gene transfection.
(1)成功地合成了2 ′-0,4 ′-C-亚甲基桥联核酸类似物(BNAs)和含有BNAs的寡核苷酸(BNA-ODNs)。BNA-ODNs具有比天然ODNs和修饰ODNs更强的双链和三链形成能力。与天然ODNs和S-ODNs的各种性质比较表明,BNA-ODNs具有良好的反义能力。(二)、我们设计并合成了具有手性柄结构和/或手性离子载体结构的新型手性维生素B_6模型化合物,发现它们对α-氨基酯和肽的N-末端不对称α-烷基化反应有效。以吡哆醛为模型化合物,成功地实现了丝氨酸衍生物与硫醇的催化β-取代反应。(3)我们合成了具有杂环结构的萤火虫荧光素类似物,取代了萤火虫荧光素分子中的苯并噻唑结构,并研究了它们的生物发光和荧光活性。结果发现,苯并咪唑衍生物通过用荧光素酶处理显示出有效的发光,而苯并恶唑衍生物对于由氧化处理诱导的荧光是有效的。(4)我们合成了具有对称结构的阳离子脂质体,并研究了由该脂质体制备的脂质体的基因转染活性。结果发现,由对称脂质组成的脂质体比具有不对称结构的脂质体更容易制备,其毒性低,并且对基因转染有效。
项目成果
期刊论文数量(188)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
S. Obika, W. Yu, A. Shimoyama, T. Uneda, T. Minami, K. Miyashita, T. Doi and T. Imanishi: "Properties of cationic liposomes composed of cationic lipid YKS-220 having an ester linkage: adequate stability, high transfection efficiency, and low cytotoxicity"
S. Obika、W. Yu、A. Shimoyama、T. Uneda、T. Minami、K. Miyashita、T. Doi 和 T. Imanishi:“由具有酯键的阳离子脂质 YKS-220 组成的阳离子脂质体的特性:足够
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Obika, T.Imanishi et al.: "Synthesis and conformation of 3', 4'-BNA monomers, 3'-0, 4'-C-methyleneribonucleosides"Tetrahedron. (印刷中). (2002)
S.Obika、T.Imanishi 等人:“3、4-BNA 单体、3-0、4-C-亚甲基核糖核苷的合成和构象”Tetrahedron(印刷中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K. Miyashita, H. Miyabe, K. Tai, H. Iwaki and T. Imanishi: "Asymmetric a-alkylation of α-amino esters using pyridoxal derivatives having a chiral ansa-structure and a chiral ionophore function: a novel example of double asymmetric induction"Tetrahedron. 5
K. Miyashita、H. Miyabe、K. Tai、H. Iwaki 和 T. Imanishi:“使用具有手性 ansa 结构和手性离子载体功能的吡哆醛衍生物对 α-氨基酯进行不对称 α-烷基化:双不对称感应“四面体.5”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S. Obika, Y. Hari, H. Inohara and T. Imanishi: "2,4'-BNA bearing unnatural nucleobases: Toward the expansion of the target sequence of double-stranded DNA in triplex formation"Nucleic Acids Res. Suppl.. 1. 171-172 (2001)
S. Obika、Y. Hari、H. Inohara 和 T. Imanishi:“带有非天然核碱基的 2,4-BNA:以三链体形式扩展双链 DNA 的靶序列”《核酸研究》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Miyashita, T.Imanishi et al.: "Oxiranes having an acridane structure as a novel chemiluminescent precursor: synthesis and chemiluminescent studies"Tetrahedron. 57・16. 3361-3367 (2001)
K. Miyashita、T. Imanishi 等:“具有吖啶结构的环氧乙烷作为新型化学发光前体:合成和化学发光研究”Tetrahedron 57・16 (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IMANISHI Takeshi其他文献
IMANISHI Takeshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IMANISHI Takeshi', 18)}}的其他基金
Development of artificial nucleic acid conjugates as base materials for genome-based drug discovery and DNA-based diagnostics
开发人工核酸缀合物作为基于基因组的药物发现和基于 DNA 的诊断的基础材料
- 批准号:
19390030 - 财政年份:2007
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study to develop novel genomic drugs by using superfunctional oligonucleotide analogues
利用超功能寡核苷酸类似物开发新型基因组药物的研究
- 批准号:
12557201 - 财政年份:2000
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of highly functional medicines targeting genomic DNA/RNA
开发针对基因组 DNA/RNA 的高功能药物
- 批准号:
09557201 - 财政年份:1997
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Synthetic Studies on Polyquinane Sesquiterpenes
聚奎烷倍半萜的合成研究
- 批准号:
63570992 - 财政年份:1988
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Physicochemical characterisation of oligonucleotides for therapeutic formulations
用于治疗制剂的寡核苷酸的物理化学表征
- 批准号:
2902101 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Studentship
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
- 批准号:
10759950 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
MICA: Single-domain antibody oligonucleotides conjugates for brain delivery of oligonucleotide therapeutics
MICA:单域抗体寡核苷酸缀合物,用于脑部递送寡核苷酸治疗剂
- 批准号:
MR/X004686/1 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Fellowship
Inducing H3F3A exon skipping with antisense oligonucleotides as an approach to treat diffuse intrinsic pontine glioma
用反义寡核苷酸诱导 H3F3A 外显子跳跃作为治疗弥漫性内源性脑桥胶质瘤的方法
- 批准号:
10677284 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
High-throughput screening and structure-guided optimization of oligonucleotides for site-directed RNA editing by ADARs.
通过 ADAR 进行定点 RNA 编辑的寡核苷酸的高通量筛选和结构引导优化。
- 批准号:
10636547 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
2023 2023 Nucleosides, Nucleotides and Oligonucleotides GRC & GRS
2023 2023 核苷、核苷酸和寡核苷酸 GRC
- 批准号:
10609239 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Preclinical efficacy and safety studies of ADAM33 oligonucleotides as new disease-modifying asthma therapy
ADAM33 寡核苷酸作为新的缓解哮喘疾病疗法的临床前疗效和安全性研究
- 批准号:
MR/X013960/1 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant
New chemistry to enhance splice-switching oligonucleotides
增强剪接转换寡核苷酸的新化学物质
- 批准号:
2890408 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Studentship
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
- 批准号:
10464020 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
使用反义寡核苷酸促进成人海马神经发生作为阿尔茨海默氏病的治疗
- 批准号:
10484703 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:














{{item.name}}会员




